Reich et al. showed that the novel selective MMP-2 inhibitor cyclopentylcarbamoylphosphonic acid similarly reduced the number of lung metastases and tumor growth in an in vivo B16-F10 mouse melanoma model [135]. This evidence concerns the gene MMP2 and neoplasm.